Andre Biuckians, MD
Vascular Surgery · Bel Air, MDNPI 1184719304
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (54.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Philips North America LLC accounts for 63.4% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2023 at $9,979 and has fallen 60.6% since, to $3,934 in 2025.
Across 143 payments — averaging $169.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$15K
- Angiodynamics, Inc.$4K
- Endologix LLC$1K
- Medtronic$943
- Silk Road Medical, Inc.$468
- Nevro Corp.$413
- plus $2K from 17 others
What the payments were for
- Consulting fees$13,29055%
- Speaking & faculty fees$9754%
- Travel & lodging$3,69615%
- Food & beverage$6,31526%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Philips North America LLC | 25 | $15,403 |
| Angiodynamics, Inc. | 16 | $3,688 |
| Endologix LLC | 9 | $1,105 |
| Medtronic(2 entities) | 24 | $943 |
| Silk Road Medical, Inc. | 9 | $468 |
| Nevro Corp. | 4 | $413 |
| W. L. Gore & Associates, Inc. | 3 | $367 |
| Boston Scientific | 12 | $363 |
| Bard Peripheral Vascular, Inc. | 8 | $362 |
| Inari Medical, Inc. | 2 | $198 |
| Johnson & Johnson | 11 | $193 |
| Penumbra, Inc. | 1 | $147 |
| Stryker | 1 | $131 |
| Abbott | 3 | $124 |
| Cook Medical LLC | 6 | $115 |
| Venclose Inc. | 1 | $61 |
| Nipro Medical Corporation | 1 | $58 |
| BD | 1 | $37 |
| Cardinal Health 200 LLC | 2 | $34 |
| Longeviti Neuro Solutions Inc | 1 | $21 |
| Akorn, Inc. | 1 | $20 |
| Lemaitre Vascular, Inc. | 1 | $15 |
| Medela LLC | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- (9520) IGT Devices Undivided$10,537
- IGT Devices Und$3,120
- AngioVac$1,781
- AlphaVac$1,282
- IGT D Peripheral$975
- Torus Stent Graft System$971
- ENDOCROSS Device$971
- ENROUTE Transcarotid Neuroprotection System$366
- GORE TAG Conformable Thoracic Endoprosthesis$319
- Auryon Laser System 100-120 Vac$299
- FLOWTRIEVER CATHETER, S$256
- ENROUTE Transcarotid Stent$234
- Senza$227
- Abre$157
- Penumbra System$147
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$131
- FlowTriever$131
- Varithena Administration Pack$123
- ELLIPSYS VASCULAR ACCESS SYSTEM$121
- RotarexS 6 F x 135 cm$104
How this compares
$24,276 in reported general payments places this provider in the 85th percentile of 104 vascular surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 33 | $40,237 |
| EliquisApixaban | 26 | $30,034 |
| ClopidogrelClopidogrel Bisulfate | 90 | $903 |
| Cilostazol | 12 | $289 |
| Oxycodone Hcl | 22 | $110 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $193 | $40,23733 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 104 vascular surgery providers in Maryland.
Other vascular surgery in Bel Air
- Michael OsgoodBel Air$57K
- Micah GirottiBel Air$35K
- Richard BaffordBel Air$31K
- Philip RiveraBel Air$4K
- Peter MackrellBel Air$3K
- Paul McNeillFrederick$302K
- John MartinAnnapolis$172K
- Caitlin HicksBaltimore$88K
- Shahab ToursavadkohiBaltimore$76K
- Jeffrey WangGermantown$53K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.